SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001159036-22-000019
Filing Date
2022-03-15
Accepted
2022-03-15 16:50:41
Documents
12
Period of Report
2022-03-15
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K halo-20220315.htm   iXBRL 8-K 38828
  Complete submission text file 0001159036-22-000019.txt   174395

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT halo-20220315.xsd EX-101.SCH 1915
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT halo-20220315_lab.xml EX-101.LAB 24137
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT halo-20220315_pre.xml EX-101.PRE 12520
6 EXTRACTED XBRL INSTANCE DOCUMENT halo-20220315_htm.xml XML 10826
Mailing Address 11388 SORRENTO VALLEY ROAD SAN DIEGO CA 92121-1345
Business Address 11388 SORRENTO VALLEY ROAD SAN DIEGO CA 92121-1345 (858) 794-8889
HALOZYME THERAPEUTICS, INC. (Filer) CIK: 0001159036 (see all company filings)

IRS No.: 880488686 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32335 | Film No.: 22741853
SIC: 2836 Biological Products, (No Diagnostic Substances)